Muscarinic antagonists in substantia nigra influence the decarboxylation of L-dopa in striatum.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  European Journal of Pharmacology

• Publication date

  2000-07-07

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0014-2999(00)00353-8PMID 10884514
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biotransformation of l‐DOPA to Dopamine in the Substantia Nigra of Freely Moving Rats: Effect of Dopamine Receptor Agonists and Antagonists

  1998cited by this paper
• Effect of trihexyphenidyl, a non-selective antimuscarinic drug, on decarboxylation of L-dopa in hemi-Parkinson rats.

  1998cited by this paper
• Loss of dopaminergic neurons in parkinsonism: possible role of reactive dopamine metabolites.

  1997cited by this paper
• Muscarinic Modulation of Striatal Dopamine, Glutamate, and GABA Release, as Measured with In Vivo Microdialysis

  1997cited by this paper
• Extracellular Striatal Dopamine and Glutamate After Decortication and Kainate Receptor Stimulation, as Measured by Microdialysis

  1996cited by this paper
• Circling behavior elicited by cholinergic transmission in the substantia nigra pars compacta: involvement of nicotinic and muscarinic receptors.

  1996cited by this paper
• Levodopa biotransformation in hemi-Parkinson rats: effect of dopamine receptor agonists and antagonists.

  1996cited by this paper
• Basal ganglia and movement disorders: an update.

  1996cited by this paper
• The response to levodopa in parkinson's disease: Imposing pharmacological law and order

  1996cited by this paper
• Amphetamine‐induced release of dendritic dopamine in substantia nigra pars reticulata: D1‐mediated behavioral and electrophysiological effects

  1996cited by this paper
• Dopamine receptor supersensitivity.

  1995cited by this paper
• Tonic GABA-ergic modulation of striatal dopamine release studied by in vivo microdialysis in the freely moving rat.

  1995cited by this paper
• The analysis of excitatory, inhibitory and other amino acids in rat brain microdialysates using microbore liquid chromatography.

  1995cited by this paper
• Biotransformation of locally applied l-dopa in the corpus striatum of the hemi-Parkinsonian rat studied with microdialysis

  1994cited by this paper
• Muscarinic receptor stimulation increases the spontaneous [3H]GABA release in the rat substantia nigra through muscarinic receptors localized on striatonigral terminals.

  1994cited by this paper
• Cholinergic stimulation of rostral and caudal substantia nigra pars compacta produces opposite effects on circling behavior and striatal dopamine release measured by brain microdialysis.

  1994cited by this paper
• Effect of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism: an in vivo microdialysis study comparing normal and 6-hydroxydopamine-lesioned rats.

  1993cited by this paper
• Modulation of dopamine efflux in the striatum following cholinergic stimulation of the substantia nigra in intact and pedunculopontine tegmental nucleus-lesioned rats

  1993cited by this paper
• Multiple output channels in the basal ganglia.

  1993cited by this paper
• Autoradiographic mapping of M3 muscarinic receptors in the rat brain.

  1993cited by this paper
• The effects of neurotensin on GABA and acetylcholine release in the dorsal striatum of the rat: an in vivo microdialysis study.

  1992cited by this paper
• The neostriatal mosaic: multiple levels of compartmental organization.

  1992cited by this paper
• Biotransformation of l-DOPA in striatum and substantia nigra of rats with a unilateral, nigrostriatal lesion: a microdialysis study

  1992cited by this paper
• The neostriatal mosaic: multiple levels of compartmental organization.

  1992cited by this paper
• Electrophysiology of dopaminergic and non‐dopaminergic neurones of the guinea‐pig substantia nigra pars compacta in vitro.

  1991cited by this paper
• Pharmacologically defined M1 and M2 muscarinic cholinergic binding sites in the cat's substantia nigra: development and maturity.

  1991cited by this paper
• Cholinergic input to dopaminergic neurons in the substantia nigra: a double immunocytochemical study.

  1991cited by this paper
• Muscarine depolarizes rat substantia nigra zona compacta and ventral tegmental neurons in vitro through M1-like receptors.

  1990cited by this paper
• Functional architecture of basal ganglia circuits: neural substrates of parallel processing.

  1990cited by this paper
• The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones.

  1990cited by this paper
• Localization of m5 muscarinic receptor mRNA in rat brain examined by in situ hybridization histochemistry.

  1990cited by this paper
• Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia.

  1990cited by this paper
• Differential effects of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism in freely moving rats.

  1989cited by this paper
• The functional anatomy of basal ganglia disorders.

  1989cited by this paper
• Adverse Effects of Levodopa in Parkinson’s Disease

  1989cited by this paper
• Cholinergic projections to the substantia nigra from the pedunculopontine and laterodorsal tegmental nuclei.

  1989cited by this paper
• Nicotinic excitation of rat ventral tegmental neurones in vitro studied by intracellular recording

  1989cited by this paper
• Innervation of substantia nigra neurons by cholinergic afferents from pedunculopontine nucleus in the rat: neuroanatomical and electrophysiological evidence.

  1987cited by this paper
• A cholinergic projection to the rat substantia nigra from the pedunculopontine tegmental nucleus.

  1987cited by this paper
• Muscarinic cholinergic receptor subtypes in the rat brain. I. Quantitative autoradiographic studies.

  1986cited by this paper
• A Search for Receptors Modulating the Release of γ‐[3H]Aminobutyric Acid in Rabbit Caudate Nucleus Slices

  1986cited by this paper
• Muscarinic cholinergic receptor subtypes in the human brain. II. Quantitative autoradiographic studies.

  1986cited by this paper
• Quantitative light microscopic autoradiographic localization of cholinergic muscarinic receptors in the human brain: brainstem.

  1984cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• Dopaminergic dendrites in the pars reticulata of the rat substantia nigra and their striatal input. Combined immunocytochemical localization of tyrosine hydroxylase and anterograde degeneration.

  1981cited by this paper
• Relationship between tardive dyskinesia, l-Dopa-induced hyperkinesia and parkinsonism

  1977cited by this paper
• The Rat Drain. A Stereotaxic Atlas

  1964cited by this paper

• Movement disorders associated with acetylcholinesterase inhibitors in Alzheimer’s dementia: A systematic review

  2025cites this paper
• Motor activity-induced dopamine release in the substantia nigra is regulated by muscarinic receptors.

  2010cites this paper
• Dopamine and the regulation of movements - significance of nigral and striatal dopamine release in normal, hemiparkinsonian and dyskinetic rats

  2009cites this paper
• Drugs used to treat Parkinson's disease, present status and future directions.

  2008cites this paper
• Anatomy, function and regulation of neuropeptide EI (NEI).

  2008cites this paper
• Antagonist of M1 Muscarinic Acetylcholine Receptor Prevents Neurotoxicity Induced by Amphetamine via Nitric Oxide Pathway

  2008cites this paper
• Donepezil-induced chorea in Alzheimer's disease

  2007cites this paper
• Muscarinic M2 and M4 receptors in anterior cingulate cortex: relation to neuropsychiatric symptoms in dementia with Lewy bodies.

  2005cites this paper
• Midbrain muscarinic receptor mechanisms underlying regulation of mesoaccumbens and nigrostriatal dopaminergic transmission in the rat

  2005cites this paper
• M4 muscarinic receptors regulate the dynamics of cholinergic and dopaminergic neurotransmission: relevance to the pathophysiology and treatment of related central nervous system pathologies

  2004cites this paper
• [Lesions in the pars compacta substantiae nigra and the subthalamic nucleus modify the density of muscarinic receptors in different nuclei of the basal ganglia].

  2004cites this paper
• Neurotransmitter relationships in the hypoxia-challenged cat carotid body.

  2003cites this paper
• Muscarinic modulation of hypoxia-induced release of catecholamines from the cat carotid body.

  2002cites this paper
• Synthesis and pharmacology of benzoxazines as highly selective antagonists at M(4) muscarinic receptors.

  2002cites this paper
• Cholinergic modulation of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.

  2002cites this paper
• Annals of General Psychiatry Annals of General Psychiatry Intractable Hiccups (singultus) Abolished by Risperidone, but Not by Haloperidol Intractable Hiccups (singultus) Abolished by Risperidone, but Not by Haloperidol

  year unknowncites this paper